Abstract The patent describes the discovery and application of a specific strain of Limosilactobacillus reuteri (LR38), preserved under CGMCC No.24408, which is effective in improving polycystic ovary syndrome (PCOS). The strain addresses PCOS-related symptoms such as metabolic level disorders and abnormal sex hormone levels, providing a potential preventive, alleviating, or therapeutic...